Interaction index and different methods for determining drug interaction in combination therapy

被引:109
|
作者
Lee, J. J.
Kong, M.
Ayers, G. D.
Lotan, R.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[2] Univ Louisville, Dept Biostat & Bioinformat, Louisville, KY 40292 USA
[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA
[4] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
关键词
antagonism; drug interaction; Loewe additivity model; response surface model; synergy;
D O I
10.1080/10543400701199593
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studying and understanding the joint effect of combined treatments is important in pharmacology and in the development of combination therapies. The Loewe additivity model is one of the best general reference models for evaluating drug interactions. Based on this model, synergy occurs when the interaction index is less than one, while antagonism occurs when interaction index is greater than one. We expound the meaning of the interaction index, and propose a procedure to calculate the interaction index and its associated confidence interval under the assumption that the dose-effect curve for a single agent follows Chou and Talalay's median effect equation. In addition, we review four response surface models based on the Loewe additivity model using a single parameter to determine drug interactions. We describe each of these models in the context of Loewe additivity model and discuss their relative advantages and disadvantages. We also provide S-PLUS/R code for each approach to facilitate the implementation of these commonly used methods.
引用
收藏
页码:461 / 480
页数:20
相关论文
共 50 条
  • [12] METHODS OF DETERMINING INTERACTION POTENTIALS OF ATOMS MOLECULES AND IONS
    LEONAS, VB
    SAMUILOV, EV
    HIGH TEMPERATURE, 1966, 4 (05) : 664 - &
  • [13] DRUG-INTERACTION - MEPERIDINE AND CHLORPROMAZINE, A TOXIC COMBINATION
    STAMBAUGH, JE
    WAINER, IW
    JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (04): : 140 - 146
  • [14] Risk of drug interaction: Combination of antidepressants and other drugs
    Miyasaka, LS
    Atallah, AN
    REVISTA DE SAUDE PUBLICA, 2003, 37 (02): : 212 - 215
  • [15] Rhabdomyolysis due to warfarin and atorvastatin combination therapy in a patient with ischemic heart disease: (A drug interaction)
    Soliemanabad, Saeed Kargar
    Rasouli, Kimia
    Zakariaei, Zakaria
    Soleymani, Mostafa
    Aliabadi, Parastoo Karimi
    ANNALS OF MEDICINE AND SURGERY, 2022, 75
  • [16] Pharmacokinetic drug–drug interaction assessment of peptibody trebananib in combination with chemotherapies
    Benjamin Wu
    Rebeca Melara
    Erik Rasmussen
    Lei Zhou
    Teresa Wong
    Cindy Kitahara
    Mark Ma
    Jessica Lu
    Erick Gamelin
    Cheryl A. Pickett
    Yu-Nien Sun
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 243 - 250
  • [17] Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
    Garg, Varun
    Shen, Jinshan
    Li, Chonghua
    Agarwal, Sagar
    Gebre, Asfiha
    Robertson, Sarah
    Huang, Jiayin
    Han, Linda
    Jiang, Licong
    Stephan, Kristin
    Wang, Linda T.
    Lekstrom-Himes, Julie
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (03): : 267 - 275
  • [18] THRESHOLDS OF HUMAN SENSITIVITY AS AN INDEX OF DRUG-INTERACTION
    KOMENDANTOVA, MV
    ZORYAN, EV
    ALEXANDROVA, GM
    PASHUK, LK
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1982, 45 (03): : 41 - 45
  • [19] Determining the Geological Strength Index (GSI) using different methods
    Vasarhelyi, B.
    Somodi, G.
    Krupa, A.
    Kovacs, L.
    ROCK MECHANICS AND ROCK ENGINEERING: FROM THE PAST TO THE FUTURE, VOL 2, 2016, : 1049 - 1054
  • [20] Possible interaction between sildenafil and HIV combination therapy
    Nandwani, R
    Gourlay, Y
    LANCET, 1999, 353 (9155): : 840 - 840